Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
9,173,287
-
Shares change
-
-375,981
-
Total reported value, excl. options
-
$36,785,829
-
Value change
-
-$692,673
-
Number of buys
-
28
-
Number of sells
-
-23
-
Price
-
$4.01
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2019
62 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q4 2019.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,173,287 shares
.
Largest 10 shareholders include FMR LLC (2,871,246 shares), Bellevue Group AG (1,550,669 shares), BlackRock Inc. (908,796 shares), VICTORY CAPITAL MANAGEMENT INC (495,451 shares), VANGUARD GROUP INC (355,901 shares), FRANKLIN RESOURCES INC (326,900 shares), Prosight Management, LP (320,000 shares), STATE STREET CORP (228,184 shares), CHI Advisors LLC (154,255 shares), and NORTHERN TRUST CORP (143,047 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.